Federal Cannabis Rescheduling: Evidence-Based Policy Over Celebrity Opinion
The debate over federal cannabis rescheduling requires evidence-based policy decisions rather than celebrity-driven discourse. Current Schedule I classification restricts vital clinical research and creates legal barriers that complicate patient access…
SubscriberWrites: From Shiva to Science: India’s Uneasy Relationship with Cannabis
India cannabis policy changes reflect a complex balance between tradition and modern science. Understanding these changes is crucial for clinicians treating diverse patient populations. This update highlights emerging regulatory shifts and their clinical…
Artemis II sends back never-before-seen images of the moon – MSN
The Artemis II mission images provide unprecedented views of the moon. NASA's lunar photos from Artemis II reveal new details of the moon's surface. These Artemis II mission images mark a milestone in space exploration.
NATO Scrambles to Ready Its Arctic Defences | Watch – MSN
The NATO Arctic defence strategy is a key focus as military readiness intensifies in 2026. This article covers NATO's efforts to strengthen Arctic security and defence. Understanding the geopolitical implications of the NATO Arctic defence strategy is…
Cannabinoids vs. Opioids: Exploration and Evolution of Pain Management
Cannabinoids pain management offers a promising alternative to traditional opioids. Research shows medicinal cannabis can reduce opioid consumption and improve patient outcomes. Understanding cannabinoids pain management is key to evolving future pain…
Synthetic cannabinoids cause more convulsion and hypothermia in mice than cannabis-derived cannabinoids.
Comparison of the Neurotoxic and Seizure-Inducing Effects of Synthetic and Endogenous Cannabinoids with D9-Tetrahydrocannabinol In Summary Synthetic cannabinoids are commonly used as recreational drugs. However, an increasing number of clinical reports…
Activation of a cannabinoid receptor represents a promising therapeutic strategy for Parkinson’s Disease
Activation cannabinoid receptor Parkinsons offers a promising therapeutic strategy by promoting neuroprotection. The CB2 receptor agonist AM1241 improves motor function and dopaminergic neuron survival. This mechanism involves the Xist/miR-133b-3p/Pitx3…